Interim Report Q3 January – March-2026
Preview text: Interim Report Q3 January – March-2026
Image not available
No image available for this email.
- Subject
- Interim Report Q3 January – March-2026
- Preview text
- Interim Report Q3 January – March-2026
- From
- info@
hamletbiopharma.com - Brand
- Hamlet BioPharma
- ESP
- Mailchimp
- Sent
- Fri May 22, 2026, 3:00 AM ET
- Size
- 54 KB
- Images
- 10
- Links
- 9, 2 of them buttons
- Subject length
- 38 characters
Against Hamlet BioPharma's usual
Sent in the 3 AM hour, which holds 14% of its emails; 18% arrive in the 4 AM hour. The subject is 38 characters; its average is 45.
Sent just before and after
| Jun 17, 2026 5:59 AM | Pressrelease – Lund, June 17th, 2026 | |
| Jun 10, 2026 8:44 AM | Press release – Lund, June 10th, 2026 | |
| Jun 8, 2026 10:00 AM | Pressrelease – Lund, 8 juni, 2026 | |
| May 22, 2026 3:00 AM | Interim Report Q3 January – March-2026 (this email) | |
| May 21, 2026 5:29 AM | PRESS RELEASE Lund, May 21st, 2026 | |
| May 18, 2026 9:29 AM | Press release – Lund, May 18th, 2026 | |
| Apr 23, 2026 10:29 AM | Monthly investor meeting on the 29th of April, 2026 |
More from Hamlet BioPharma
All Hamlet BioPharma emailsHamlet BioPharma publicerar årsredovisning 2025/2026
Oct 30, 2026 4:01 AM
PRESS RELEASE Lund, October 28th, 2026
Oct 28, 2026 6:09 AM
